checkAd

     680  0 Kommentare LL Capital Corp. Announces Closing of Qualifying Transaction and Name Change to Syncordia Technologies and Healthcare Solutions, Corp. - Seite 2

    Following completion of the Qualifying Transaction, the Corporation has 19,643,635 post-Consolidation Common Shares issued and outstanding. Assuming the conversion of all outstanding options, warrants and stock options, 24,416,909 Common Shares are outstanding on a fully diluted basis.

    Escrowed Securities

    Pursuant to the terms of a surplus security escrow agreement dated June 29, 2015 among the Corporation, Equity Financial Trust Company as escrow agent and certain escrow securityholders, an aggregate of 4,356,000 post-Consolidation Common Shares have been placed in escrow, whereby 10% of such securities will be released immediately upon the issuance of the Exchange Bulletin and the balance of such securities will be released in accordance with the following schedule: (i) 20% six months following the issuance of the Exchange Bulletin; (ii) 30% 12 months following the issuance of the Exchange Bulletin; and (iii) 40% 18 months following the issuance of the Exchange Bulletin.

    There are two non-principal former shareholders of Syncordia Common Shares who hold an aggregate of 210,000 post-Consolidation Common Shares that are subject to share resale restrictions (each, an "SSRR") equivalent to Tier 1 value escrow requirements. 25% of such securities will be released immediately upon the issuance of the Exchange Bulletin and the balance of such securities will be released in equal tranches of 25% every six months thereafter.

    Certain non-principal former shareholders of Syncordia who, upon closing of the Qualifying Transaction, now hold an aggregate of 1,030,000 post-Consolidation Common Shares are subject to SSRRs that permit such shares to be released pursuant to a four month hold with 20% released each month with the first release on closing of the Qualifying Transaction.

    Directors and Officers

    As a result of the closing of the Qualifying Transaction, the directors and officers of the Corporation are now:

    Michael Franks Chief Executive Officer and Director
    Lawrence Davis Chief Financial Officer
    Michael Plotkin Chief Technology Officer
    Christopher Martin Chief Strategy Officer and Director
    Michael DiMino Director
    Shaun Francis Director
    James Eaton Director
    Kenneth Stults Director

    Further details on the Qualifying Transaction are set out in the Corporation's filing statement dated June 25, 2015 available under the Corporation's profile at www.sedar.com.

    Seite 2 von 3



    Verfasst von Marketwired
    LL Capital Corp. Announces Closing of Qualifying Transaction and Name Change to Syncordia Technologies and Healthcare Solutions, Corp. - Seite 2 TORONTO, ONTARIO--(Marketwired - June 29, 2015) - Syncordia Technologies and Healthcare Solutions, Corp. (formerly "LL Capital Corp.") (the "Corporation") (TSX VENTURE:LLA.P) is pleased to announce that, further to its press releases dated April 13, …